Action grants to organise and collect data to understand the safety, quality and efficacy of therapies applied in the field of assisted reproduction and based on haematopoietic stem cells
Programme Category
Programme Name
Programme Description
The Programme aims to improve and promote health in the Union to reduce the burden of communicable and non-communicable diseases by:
- protecting people from serious cross-border health threats
- improving the availability, accessibility and affordability of medicines, medical devices and other crisis-related products in the EU
- strengthening national health systems
Identifier Code
Call
Summary
This action will aim to collect and organise in registries data on the safety, quality and efficacy of therapies applied in the field of medically assisted reproduction (MAR) and haematopoietic stem cell transplantation.
Detailed Call Description
Hematopoietic stem cells play a significant role in the area of cancer immunotherapy, in particular in the treatment of liquid blood cancers like leukaemia and lymphoma.
The action supports the policy priority to respond to the COVID-19 crisis and implements the EU4Health Programme’s general objective of improving the availability, accessibility and affordability of medicinal products and medical devices, and crisis-relevant products in the Union, and of supporting innovation.
This action will support Union data collection, aggregation and analysis on the use and outcome of therapies in the fields of:
- assisted reproduction;
- haematopoietic stem cells.
For both (a) and (b) it will facilitate the design, development and management of dedicated IT solutions with and for medical/healthcare professionals.
Call Total Budget
Financing percentage by EU or other bodies / Level of Subsidy or Loan
60%
Applicants can apply for a higher project funding rate (maximum 80%) if your project is of ‘exceptional utility’.
Thematic Categories
- Health
Eligibility for Participation
- Central Government
- International Organisations
- NGOs
- Non Profit Organisations
- Private Bodies
- State-owned Enterprises
Eligibility For Participation Notes
In order to be eligible for funding, the applicants (beneficiaries and affiliated entities) must:
- be legal entities (public or private bodies) created under Union law or an international organisation, or
- be established in one of the eligible countries, i.e.:
- EU Member States (including overseas countries and territories linked to it (OCTs)
- eligible non-EU countries: EEA countries and countries associated to the EU4Health Programme (third countries, candidate countries and potential candidate countries, neighbourhood countries) or countries which are in ongoing negotiations for an association agreement and where the agreement enters into force before grant signature.
Call Opening Date
Call Closing Date
National Contact Point(s)
Ministry of Health, Department of European Affairs
Ms MAKRIGIORGI Elena
emakrigiorgi@moh.gov.cy
(Publish Date: 29/10/2021-for internal use only)
EU Contact Point
Stefan DE KEERSMAECKER
Telephone: +32 2 298 46 80
Email: stefan.de-keersmaecker@ec.europa.eu
Darragh CASSIDY
Telephone: +32 2 298 39 78
Email: darragh.cassidy@ec.europa.eu